- Home
- EEFT vs RYTM Comparison
EEFT vs RYTM Comparison
Compare EEFT & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EEFT
- RYTM
- Stock Information
- Founded
- EEFT 1994
- RYTM 2008
- Country
- EEFT United States
- RYTM United States
- Employees
- EEFT N/A
- RYTM N/A
- Industry
- EEFT EDP Services
- RYTM Biotechnology: Pharmaceutical Preparations
- Sector
- EEFT Technology
- RYTM Health Care
- Exchange
- EEFT Nasdaq
- RYTM Nasdaq
- Market Cap
- EEFT 4.7B
- RYTM 3.8B
- IPO Year
- EEFT 1997
- RYTM 2017
- Fundamental
- Price
- EEFT $108.28
- RYTM $61.33
- Analyst Decision
- EEFT Buy
- RYTM Strong Buy
- Analyst Count
- EEFT 7
- RYTM 12
- Target Price
- EEFT $125.57
- RYTM $76.75
- AVG Volume (30 Days)
- EEFT 400.3K
- RYTM 632.6K
- Earning Date
- EEFT 07-17-2025
- RYTM 05-07-2025
- Dividend Yield
- EEFT N/A
- RYTM N/A
- EPS Growth
- EEFT 18.66
- RYTM N/A
- EPS
- EEFT 6.80
- RYTM N/A
- Revenue
- EEFT $4,048,300,000.00
- RYTM $136,863,000.00
- Revenue This Year
- EEFT $10.43
- RYTM $37.88
- Revenue Next Year
- EEFT $7.92
- RYTM $72.84
- P/E Ratio
- EEFT $15.92
- RYTM N/A
- Revenue Growth
- EEFT 7.73
- RYTM 48.88
- 52 Week Low
- EEFT $85.24
- RYTM $35.35
- 52 Week High
- EEFT $117.66
- RYTM $68.58
- Technical
- Relative Strength Index (RSI)
- EEFT 55.95
- RYTM 51.78
- Support Level
- EEFT $104.14
- RYTM $58.72
- Resistance Level
- EEFT $109.65
- RYTM $63.24
- Average True Range (ATR)
- EEFT 2.31
- RYTM 2.43
- MACD
- EEFT -0.36
- RYTM -0.15
- Stochastic Oscillator
- EEFT 45.85
- RYTM 65.51
About EEFT Euronet Worldwide Inc.
Euronet Worldwide Inc is a provider of electronic financial transaction solutions. It offers payment and transaction processing and distribution solutions to financial institutions, retailers, service providers, and individual consumers. The company's product offerings include comprehensive ATM, POS, card outsourcing, card issuing and merchant acquiring services, software solutions, money transfer services, etc. Its reportable operating segments are EFT Processing, epay, and Money Transfer. Maximum revenue is derived from its Money Transfer segment, which provides money transfer services across the world under the brand names Ria, AFEX, IME, and xe. Geographically, the company generates maximum revenue from the United States, followed by Germany, India, France, Greece, and other regions.
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its lead asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.